血液衍生物作为单一疗法和组合疗法:治疗伤口愈合的有希望的策略
Majid Zamani1, Mohammad Masumzadeh2, Mohammadreza Mohammadi Hosn3
1Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Regenerative therapy
|November 17, 2025
概括
血小板丰富血等血液衍生物通过提供生长因子来增强伤口愈合. 本综述探讨了它们的制备,成分和用于慢性伤口管理的临床用途.
科学领域:
- 再生医学是一种再生医学.
- 生物材料科学 生物材料科学
- 组织工程是组织工程.
背景情况:
- 慢性伤口带来了重大的临床和社会经济挑战.
- 延迟伤口愈合需要先进的治疗策略.
- 血液制品为组织修复提供了再生潜力.
研究的目的:
- 提供血液衍生物用于伤口愈合的全面概述.
- 分析这些产品的特性,制备和成分.
- 评估它们在促进伤口修复方面的临床有效性.
主要方法:
- 关于血液衍生伤口愈合产品的文献综述.
- 分析富含血小板的血,富含血小板的纤维素,血小板溶解物和自身条件的血清.
- 检查制备技术,生物化学概况和临床应用.
主要成果:
- 血液衍生物集中生长因子和细胞因子,促进愈合.
- 每种产品类型都有独特的优势和局限性,这取决于制备和成分.
- 这些产品可以单独或组合疗法,自主或异构使用.
结论:
- 血液衍生物是伤口愈合的有价值的治疗选择.
- 它们的应用可以根据特定的伤口类型和治疗方案量身定制.
- 这些药物在多式联络伤口管理方案中显示出作为独立或辅助疗法的前景.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis III: Interprofessional Care
271
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
271
Introduction to Hemostasis
13.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.2K
Blood Transfusion and Agglutination
14.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
14.0K
Extrinsic and Intrinsic Pathways of Hemostasis
11.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.9K
Venous Thrombosis IV: Nursing Management
190
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
190


